FDA Panel Rejects MDMA for PTSD Application, But Recommendation Is Not Binding [FEATURE]
The Psychopharmacologic Drugs Advisory Committee had doubts approving a treatment program that uses MDMA in psychotherapy as a treatment for Post Traumatic Stress Disorder. Advocates are dismayed and say it's a lifesaver.